Journal of International Oncology ›› 2014, Vol. 41 ›› Issue (1): 7-11.doi: 10.3760/cma.j.issn.1673422X.2014.01.003
Previous Articles Next Articles
XU Yue, ZHONG Fei, SUN Guo-Ping
Online:
2014-01-08
Published:
2014-01-22
Contact:
Sun Guoping, E-mail: sunguoping@ahmu.edu.cn
E-mail:sunguoping@ahmu.edu.cn
XU Yue, ZHONG Fei, SUN Guo-Ping. Long non-coding RNA and tumor[J]. Journal of International Oncology, 2014, 41(1): 7-11.
[1] Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression[J]. Genome Res, 2012, 22(9):17751789. [2] Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs[J]. Mol Cell, 2011, 43(6):904914. [3] Gutschner T, Hmmerle M, Eissmann M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells[J]. Cancer Res, 2013, 73(3):11801189. [4] Schmidt LH, Spieker T, Koschmieder S, et al. The long noncoding MALAT1 RNA indicates a poor prognosis in nonsmall cell lung cancer and induces migration and tumor growth[J]. J Thorac Oncol, 2011, 6(12):19841992. [5] Tano K, Mizuno R, Okada T, et al. MALAT1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motilityrelated genes[J]. FEBS Lett, 2010, 584(22):45754580. [6] Tripathi V, Shen Z, Chakraborty A, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor BMYB[J]. PLoS Genet, 2013, 9(3):e1003368. [7] Tsang WP, Ng EK, Ng SS, et al. Oncofetal H19derived miR675 regulates tumor suppressor RB in human colorectal cancer[J]. Carcinogenesis, 2010, 31(3):350358. [8] Zhang L, Yang F, Yuan JH, et al. Epigenetic activation of the miR200 family contributes to H19mediated metastasis suppression in hepatocellular carcinoma[J]. Carcinogenesis, 2013, 34(3):577586. [9] Huang JF, Guo YJ, Zhao CX, et al. Hepatitis B virus X protein (HBx)related long noncoding RNA (lncRNA) downregulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin[J]. Hepatology, 2013, 57(5):18821892. [10] Pan YF, Qin T, Feng L, et al. Expression profile of altered long noncoding RNAs in patients with HBVassociated hepatocellular carcinoma[J]. J Huazhong Univ Sci Technolog Med Sci, 2013, 33(1):96101. [11] Yang F, Zhang L, Huo XS, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans[J]. Hepatology, 2011, 54(5):16791689. [12] Lu L, Zhu G, Zhang C, et al. Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer[J]. Breast Cancer Res Treat, 2012, 136(3):875883. [13] Nakagawa T, Endo H, Yokoyama M, et al. Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short diseasefree survival in human nonsmall cell lung cancer[J]. Biochem Biophys Res Commun, 2013, 436(2):319324. [14] Lv XB, Lian GY, Wang HR, et al. Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival[J]. PLoS One, 2013, 8(5):e63516. [15] Wu W, Bhagat TD, Yang X, et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1AS1, in Barrett′s esophagus and esophageal adenocarcinoma[J]. Gastroenterology, 2013, 144(5):956966. [16] Hajjari M, Behmanesh M, Sadeghizadeh M, et al. Upregulation of HOTAIR long noncoding RNA in human gastric adenocarcinoma tissues[J]. Med Oncol, 2013, 30(3):670. [17] Xu ZY, Yu QM, Du YA, et al. Knockdown of long noncoding RNA HOTAIR suppresses tumor invasion and reverses epithelialmesenchymal transition in gastric cancer[J]. Int J Biol Sci, 2013, 9(6):587597. [18] Arita T, Ichikawa D, Konishi H, et al. Circulating long noncoding RNAs in plasma of patients with gastric cancer[J]. Anticancer Res, 2013, 33(8):31853193. [19] Kam Y, Rubinstein A, Naik S, et al. Detection of a long noncoding RNA (CCAT1) in living cells and human adenocarcinoma of colon tissues using FITPNA molecular beacons[J]. Cancer Lett, 2013, In press. [20] Ling H, Spizzo R, Atlasi Y, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer[J]. Genome Res, 2013, 23(9):14461461. [21] Bhan A, Hussain I, Ansari KI, et al. Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol[J]. J Mol Biol, 2013, 425(19):37073722. [22] Chisholm KM, Wan Y, Li R, et al. Detection of long noncoding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma[J]. PLoS One, 2012, 7(10):e47998. [23] Augoff K, McCue B, Plow EF, et al. MiR31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triplenegative breast cancer[J]. Mol Cancer, 2012, 11:5. [24] Qin R, Chen Z, Ding Y, et al. Long noncoding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis[J]. Neoplasma, 2013, 60(5):486492. [25] Pickard MR, MourtadaMaarabouni M, Williams GT. Long noncoding RNA GAS5 regulates apoptosis in prostate cancer cell lines[J]. Biochim Biophys Acta, 2013, 1832(10):16131623. [26] Qiao HP, Gao WS, Huo JX, et al. Long noncoding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma[J]. Asian Pac J Cancer Prev, 2013, 14(2):10771082. [27] Zhang Z, Hao H, Zhang CJ, et al. Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer[J]. Zhonghua Yi Xue Za Zhi, 2012, 92(6):384387. [28] Han Y, Liu Y, Nie L, et al. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasisassociated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder[J]. Urology, 2013, 81(1):209. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[4] | Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[5] | Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353. |
[6] | Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358. |
[7] | Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[8] | Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[9] | Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[10] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[11] | Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[13] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[14] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[15] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||